Extra Strength Pain Aid

Product NDC: 69732-006
11-digit product format: 697320006
Labeler code: 69732
Product ID: 69732-006_55f8f0e5-bdb4-ceb0-e063-6294a90a6246
Type: HUMAN OTC DRUG
Nonproprietary name: Acetaminophen, Aspirin, Caffeine
Dosage form: TABLET
Route: ORAL
Labeler: Hi-Tech Nutaceuticals, LLC
Application: M013
Marketing category: OTC MONOGRAPH DRUG
Marketing start: 2020-04-30
Substance: CAFFEINE; ACETAMINOPHEN; ASPIRIN
Active strength: 65; 250; 250 mg/1; mg/1; mg/1
Pharmacologic classes: Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 24 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	69732-006-01	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	69732-006-01	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	69732-006-01	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	69732-006-01	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	69732-006-01	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	69732-006-01	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	69732-006-01	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	69732-006-01	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	69732-006-01	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	69732-006-01	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	69732-006-01	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	69732-006-01	`557ba5c1ecfa…`	`9c80585c8c6e…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: Extra Strength Pain Aid
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
CAFFEINE	65 mg/1
ACETAMINOPHEN	250 mg/1
ASPIRIN	250 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 3 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
3G6A5W338E	Internal UNII lookup
362O9ITL9D	Internal UNII lookup
R16CO5Y76E	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
308297	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
a39e4b99-700d-0f5c-e053-2a95a90a6bd3	Available on FDA.report

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
69732-006-01	2024-01-30	C162847	48780-1	1030e365-16bc-111a-e063-dadaa90a10e2	Extra Strength Pain Aid

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 14 of 79 · 1,579 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Pain Reliever	ACETAMINOPHEN	HHH Pharmaceuticals	0c66b05d-132d-4c79-abfe-415fd68bbb9c	2026-05-06	Warnings	Exact identifier application number: M013
Aspirin	ASPIRIN	Better Living Brands, LLC	5ebd04d8-52c7-4c72-a4c1-fc7fd488ea24	2026-05-06	Warnings	Exact identifier application number: M013
Back and Body Extra Strength	ASPIRIN, CAFFEINE	Cardinal Health 110, LLC. DBA Leader	519eb216-9fa6-4d60-a2a4-3310bdb5b4ab	2026-05-06	Warnings	Exact identifier application number: M013
Aspirin	ASPIRIN	Geiss, Destin & Dunn Inc.	b8f6e486-5332-4c46-ab6c-7de04c91c60b	2026-05-06	Warnings	Exact identifier application number: M013
MAX relief junior Grape	CHILDRENS ACETAMINOPHEN	ATLANTIC BIOLOGICALS CORP.	c60494f0-5a50-41da-bcb4-88178ded54b7	2026-05-05	Warnings	Exact identifier application number: M013
equate pain relief pm	ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE	WALMART INC.	85129749-c1a7-4c4a-933f-c3c4768e2cdd	2026-05-05	Warnings	Exact identifier application number: M013
Acetaminophen Extra Strength	ACETAMINOPHEN	ARMY AND AIR FORCE EXCHANGE SERVICE	f3feca65-adc1-469f-bef6-12c860599abe	2026-05-04	Warnings	Exact identifier application number: M013
Childrens Pain and Fever	ACETAMINOPHEN	Strategic Sourcing Services LLC	4dda3534-4e83-447b-be75-33dadce06c47	2026-05-04	Warnings	Exact identifier application number: M013
Aspirin Low Dose Chewable Orange	ASPIRIN	Major Pharmaceuticals	4ba6eed3-004a-4576-b7f7-685fae49cf6a	2026-05-04	Warnings	Exact identifier application number: M013
Back and Body	ASPIRIN, CAFFEINE	Kroger Company	366b58db-1ac3-427b-b42a-5f56a14e298c	2026-05-01	Warnings	Exact identifier application number: M013
Tylenol PM	ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE	Savings Distributors LLC	8ed9a9f0-d37e-5c10-e053-2a95a90a559f	2026-05-01	Warnings	Exact identifier application number: M013
Tylenol Extra Strength	ACETAMINOPHEN	Savings Distributors LLC	8ed90757-833e-f4d9-e053-2995a90a29db	2026-05-01	Warnings	Exact identifier application number: M013
Acetaminophen , Aspirin and Caffeine	ACETAMINOPHEN , ASPIRIN AND CAFFEINE	Softgel Healthcare Pvt Ltd	4543e156-1deb-666e-e063-6394a90a719c	2026-04-27	Warnings	Exact identifier application number: M013
Acetaminophen , Caffeine and pyrilamine maleate	ACETAMINOPHEN , CAFFEINE AND PYRILAMINE MALEATE	Softgel Healthcare Pvt Ltd	45478958-ad86-4d87-e063-6394a90a3c45	2026-04-27	Warnings	Exact identifier application number: M013
Medique at Home Aspirin	ASPIRIN	Sportpharm LLC	0f2aa75e-534f-478b-811e-fb492b7af9bb	2026-04-24	Warnings	Exact identifier application number: M013
Medique at Home APAP Extra Strength	ACETAMINOPHEN 500 MG	Sportpharm LLC	cc280926-ad94-4017-a04a-b4315807eacb	2026-04-24	Warnings	Exact identifier application number: M013
Aspirin	ASPIRIN	Health Pharma USA LLC	503868bb-48e0-b718-e063-6394a90a9c5b	2026-04-24	Warnings	Exact identifier application number: M013
BC CHERRY	ASPIRIN AND CAFFEINE	Medtech Products Inc.	c5fa6660-a549-49ff-ac2b-5799afa22ec5	2026-04-24	Warnings	Exact identifier application number: M013
Doans Maximum Strength	MAGNESIUM SALICYLATE	Dr. Reddy's Laboratories Inc.	c906df41-bb45-03ea-b1a8-2b9816d55c97	2026-04-24	Warnings	Exact identifier application number: M013
Extra Strength Acetaminophen	ACETAMINOPHEN	TIME CAP LABORATORIES, INC.	48912649-9fa1-a11f-e063-6294a90a8a72	2026-04-23	Warnings	Exact identifier application number: M013

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
3G6A5W338E	CAFFEINE	58-08-2	CAFFEINE
362O9ITL9D	ACETAMINOPHEN	103-90-2	ACETAMINOPHEN
R16CO5Y76E	ASPIRIN	50-78-2	ASPIRIN

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
69732-006-01	69732000601	30 TABLET in 1 BOTTLE, PLASTIC (69732-006-01)	30 tablet	2020-04-30	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Extra Strength Pain Aid	Hi-Tech Nutaceuticals, LLC \| Hi-Tech Nutraceuticals, LLC \| Hi-Tech Nuraceuticals, LLC	2026-07-06	HUMAN OTC DRUG LABEL	6